Cord blood banking industry faces scrutiny over unproven claims and high costs

FHS
July 25, 2024
4:59 am

Some private UK biobanks may be misleading expectant parents about the value of storing umbilical cord blood to treat life-threatening diseases that may arise in their child in the future, reveals an investigation by The BMJ, published today.

Meridian Bioscience Sets a New Sustainability Standard in Diagnostic Assay Development with the Launch of Two New Animal-Free Immunoassay Interference Blockers

The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch

September 7, 2023

Only a small percentage of older adults with early Alzheimer’s eligible for new treatments

Only a small percentage of older adults who are in the early stages of Alzheimer’s disease meet the eligibility criteria to receive new monoclonal antibody

August 17, 2023

AstraZeneca to build $1.5bn ADC production facility in Singapore

The ADC manufacturing facility in Singapore is set to enhance global cancer treatment supply. Credit: Volodymyr Horbovyy / Shutterstock.com. AstraZeneca is set to invest $1.5bn

May 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.